BACKGROUND: Impairments in work productivity and daily activities contribute to the burden of rheumatoid arthritis (RA). It is thus essential to use an instrument assessing both work and daily activity impairments when studying the full impact of RA on individuals. The Work Productivity and Activity Impairment (WPAI) questionnaire is such an instrument. OBJECTIVE: This study aims to linguistically validate the RA-specific WPAI (WPAI:RA) instrument in 20 new languages and to assess its content validity for individuals with RA. METHODS: The linguistic validation of the questionnaire followed a standard methodology that included comprehension test interviews (n = 5 individuals with RA per language) to assess the relevance, understanding and acceptability of the WPAI:RA. Content validity of the instrument was simultaneously investigated. RESULTS: Comprehension testing showed that the WPAI:RA questionnaire was well understood similarly across countries; minor changes were made to ensure fidelity to the original concepts and for ease of comprehension. The majority of interviewees (66/93) considered its content comprehensive and appropriate to measure their ability to work and perform daily activities. CONCLUSION: The WPAI:RA questionnaire is now linguistically validated in 20 new languages [Czech (Czech Republic), Dutch (Belgium), English (Canada and UK), French (Belgium, Canada and France), German (Germany), Hungarian (Hungary), Italian (Italy), Polish (Poland), Portuguese (Brazil), Romanian (Romania), Russian (Russia and Ukraine), Spanish (Argentina, Mexico, Spain and US) and Ukrainian (Ukraine)]. The WPAI:RA questionnaire shows good content validity. It can thus be used in multi-country clinical trials to assess RA-related impact on the patients' ability to work and perform daily activities.
BACKGROUND: Impairments in work productivity and daily activities contribute to the burden of rheumatoid arthritis (RA). It is thus essential to use an instrument assessing both work and daily activity impairments when studying the full impact of RA on individuals. The Work Productivity and Activity Impairment (WPAI) questionnaire is such an instrument. OBJECTIVE: This study aims to linguistically validate the RA-specific WPAI (WPAI:RA) instrument in 20 new languages and to assess its content validity for individuals with RA. METHODS: The linguistic validation of the questionnaire followed a standard methodology that included comprehension test interviews (n = 5 individuals with RA per language) to assess the relevance, understanding and acceptability of the WPAI:RA. Content validity of the instrument was simultaneously investigated. RESULTS: Comprehension testing showed that the WPAI:RA questionnaire was well understood similarly across countries; minor changes were made to ensure fidelity to the original concepts and for ease of comprehension. The majority of interviewees (66/93) considered its content comprehensive and appropriate to measure their ability to work and perform daily activities. CONCLUSION: The WPAI:RA questionnaire is now linguistically validated in 20 new languages [Czech (Czech Republic), Dutch (Belgium), English (Canada and UK), French (Belgium, Canada and France), German (Germany), Hungarian (Hungary), Italian (Italy), Polish (Poland), Portuguese (Brazil), Romanian (Romania), Russian (Russia and Ukraine), Spanish (Argentina, Mexico, Spain and US) and Ukrainian (Ukraine)]. The WPAI:RA questionnaire shows good content validity. It can thus be used in multi-country clinical trials to assess RA-related impact on the patients' ability to work and perform daily activities.
Authors: Louise M A Braakman-Jansen; Erik Taal; Ina H Kuper; Mart A F J van de Laar Journal: Rheumatology (Oxford) Date: 2011-12-16 Impact factor: 7.580
Authors: Dennis A Revicki; Mary Kaye Willian; Alan Menter; Kenneth B Gordon; Alexa B Kimball; Craig L Leonardi; Richard G Langley; Miriam Kimel; Martin Okun Journal: J Dermatolog Treat Date: 2007 Impact factor: 3.359
Authors: Margaret C Reilly; Katherine L Gooch; Robert L Wong; Hartmut Kupper; Désirée van der Heijde Journal: Rheumatology (Oxford) Date: 2010-01-25 Impact factor: 7.580
Authors: Andrea M Aegerter; Manja Deforth; Venerina Johnston; Markus J Ernst; Thomas Volken; Hannu Luomajoki; Beatrice Brunner; Julia Dratva; Gisela Sjøgaard; Achim Elfering; Markus Melloh Journal: BMC Musculoskelet Disord Date: 2020-06-19 Impact factor: 2.362
Authors: Antje van der Zee-Neuen; Polina Putrik; Sofia Ramiro; Andras P Keszei; Ihsane Hmamouchi; Maxime Dougados; Annelies Boonen Journal: Arthritis Res Ther Date: 2017-09-29 Impact factor: 5.156